Impact of Nutritional Changes on Nonalcoholic Fatty Liver Disease
- PMID: 30901929
- PMCID: PMC6470750
- DOI: 10.3390/nu11030677
Impact of Nutritional Changes on Nonalcoholic Fatty Liver Disease
Abstract
Non-alcoholic fatty liver disease (NAFLD) is a major global health threat due to its growing incidence and prevalence. It is becoming the leading cause of liver disease in addition to its strong association with cardio-metabolic disease. Therefore, its prevention and treatment are of strong public interest. Therapeutic approaches emphasize lifestyle modifications including physical activity and the adoption of healthy eating habits that intend to mainly control body weight and cardio-metabolic risk factors associated with the metabolic syndrome. Lifestyle interventions may be reinforced by pharmacological treatment in advanced stages, though there is still no registered drug for the specific treatment of NAFLD. The purpose of this review is to assess the evidence available regarding the impact of dietary recommendations against NAFLD, highlighting the effect of macronutrient diet composition and dietary patterns in the management of NAFLD.
Keywords: NAFLD; NASH; diet; macronutrients.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals.Nutrients. 2017 Sep 26;9(10):1065. doi: 10.3390/nu9101065. Nutrients. 2017. PMID: 28954437 Free PMC article. Review.
-
Dietary Composition Independent of Weight Loss in the Management of Non-Alcoholic Fatty Liver Disease.Nutrients. 2017 Jul 26;9(8):800. doi: 10.3390/nu9080800. Nutrients. 2017. PMID: 28933748 Free PMC article. Review.
-
Lifestyle and Dietary Interventions in the Management of Nonalcoholic Fatty Liver Disease.Dig Dis Sci. 2016 May;61(5):1365-74. doi: 10.1007/s10620-016-4153-y. Dig Dis Sci. 2016. PMID: 27052013 Review.
-
Nonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment options.Drug Des Devel Ther. 2015 Aug 20;9:4835-45. doi: 10.2147/DDDT.S64877. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26316717 Free PMC article. Review.
-
Treatment of NAFLD with diet, physical activity and exercise.J Hepatol. 2017 Oct;67(4):829-846. doi: 10.1016/j.jhep.2017.05.016. Epub 2017 May 23. J Hepatol. 2017. PMID: 28545937 Review.
Cited by
-
Non-Necroptotic Roles of MLKL in Diet-Induced Obesity, Liver Pathology, and Insulin Sensitivity: Insights from a High-Fat, High-Fructose, High-Cholesterol Diet Mouse Model.Int J Mol Sci. 2024 Feb 28;25(5):2813. doi: 10.3390/ijms25052813. Int J Mol Sci. 2024. PMID: 38474061 Free PMC article.
-
Fibroblast Growth Factor 21: A More Effective Biomarker Than Free Fatty Acids and Other Insulin Sensitivity Measures for Predicting Non-alcoholic Fatty Liver Disease in Saudi Arabian Type 2 Diabetes Patients.Cureus. 2023 Dec 14;15(12):e50524. doi: 10.7759/cureus.50524. eCollection 2023 Dec. Cureus. 2023. PMID: 38222178 Free PMC article.
-
TRIM56 protects against nonalcoholic fatty liver disease by promoting the degradation of fatty acid synthase.J Clin Invest. 2024 Jan 11;134(5):e166149. doi: 10.1172/JCI166149. J Clin Invest. 2024. PMID: 38206764 Free PMC article.
-
Evaluation of Dietary and Alcohol Drinking Patterns in Patients with Excess Body Weight in a Spanish Cohort: Impact on Cardiometabolic Risk Factors.Nutrients. 2023 Nov 17;15(22):4824. doi: 10.3390/nu15224824. Nutrients. 2023. PMID: 38004218 Free PMC article.
-
High Extra Virgin Olive Oil Consumption Is Linked to a Lower Prevalence of NAFLD with a Prominent Effect in Obese Subjects: Results from the MICOL Study.Nutrients. 2023 Nov 4;15(21):4673. doi: 10.3390/nu15214673. Nutrients. 2023. PMID: 37960329 Free PMC article.
References
-
- European Association for the Study of the Liver (EASL) European Association for the Study of Diabetes (EASD) European Association for the Study of Obesity (EASO) EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol. 2016;64:1388–1402. doi: 10.1016/j.jhep.2015.11.004. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
